DANIEL NETHERTON: Open Payments
NPI 1346763398 · NEWBERRY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 24 payments from 12 companies in 2025. Trend: 2023 $631 · 2024 $443 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
| Amgen Inc. | 3 | $53 |
| Indivior Inc. | 2 | $40 |
| PFIZER INC. | 2 | $33 |
| ABBVIE INC. | 2 | $31 |
| Axsome Therapeutics, Inc. | 2 | $28 |
| Corcept Therapeutics | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
Products named: CAPLYTA, JARDIANCE, OTEZLA, SUBLOCADE, NURTEC ODT, VRAYLAR, Auvelity, Korlym.
Industry payments across MI — which companies pay providers there.
